<!DOCTYPE html>

<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>Relative expression of KLK5 to LEKTI is associated with aggressiveness of oral squamous cell carcinoma.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="Relative expression of KLK5 to LEKTI is associated with aggressiveness of oral squamous cell carcinoma." class="clickable-image" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f39/7708696/c24507b2036b/gr1.jpg"/> </div> <div class="text-side"> <h1>Relative expression of KLK5 to LEKTI is associated with aggressiveness of oral squamous cell carcinoma.</h1> <p>KLK5 expression decreases in OSCCs bearing higher levels of LEKTIA, D, G and J) Representative H&amp;E staining of oral mucosa (A, O.M., n = 50), premalignant hyperkeratotic lesion (D, P.L., n = 50), well-differentiated OSCC (G, W.D.C., n = 122), and poorly differentiated OSCC (J, P.D.C., n = 79), bar: 25 µm. B, E, H and K) Representative IHC staining of LEKTI in O.M. (B), P.L. (E), W.D.C. (H), and P.D.C. (K), bar: 25 µm. C, F, I and L) Representative IHC staining of KLK5 in O.M. (C), P.L. (F), W.D.C. (I), and P.D.C. (L), bar: 25 µm. Black arrows indicate LEKTI-immunostained areas; Red arrows indicate KLK5-immunostained areas; Black arrowheads indicate dysplastic cells; Yellow arrowheads indicate nuclear polymorphism; Blue arrowheads indicate atypical mitosis; Asterisks indicate keratin pearls. M) Quantification of LEKTI expression in each experimental group,% of immunostained area. O.M., circles; P.L., squares; W.D.C., triangles; P.D.C., inverted triangles. Kruskal Wallis test followed by Dunn's Multiple Comparison test; p&lt;0.0005[***]. N) Quantification of KLK5 expression in each experimental group,% of immunostained area. O.M., circles; P.L., squares; W.D.C., triangles; P.D.C., inverted triangles. Kruskal Wallis test followed by Dunn's Multiple Comparison test; p&lt;0.05[*]; p&lt;0.0005[***]. O) KLK5 protein expression in O.M (n = 50, circles), P.L. (n = 50, triangles) and O.S.C.C.s. samples (n = 201, diamonds) harboring low LEKTI (up to 1% of O.M. immunostaining, black circles, black triangles and black diamonds) and high LEKTI expression (&gt;1% of O.M. immunostaining, gray circles, gray triangles and gray diamonds). Statistical analysis: ANOVA; p&lt;0.05 [*]; p&lt;0.005 [**].</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/33260070/" target="_blank">33260070</a></p><p>Type: Premalignant/Malignant, Category: Keratinocytic</p>
</div> </div></div></body></html>